› $150,000,000 verdict in personal injury case
A Missouri woman is seeking more than $600,000 in damages from the makers of Reglan (metoclopramide) for not adequately warning her of the risk of a serious, permanent, disabling neurological condition known as Tardive Dyskinesia.
Questcor Pharmaceuticals Inc. has just released the study results of its Phase II clinical trial on a metoclopramide nasal spray for the treatment of diabetic gastroparesis, a condition in which contents remain in the stomach for a longer period of time than normal. Left untreated, gastroparesis can lead to fluctuations in blood glucose, general malnutrition, intestinal obstruction and bacterial infection.
Laura Tennant wants answers. The former editor of the Leader-Courier was prescribed Reglan more than a year ago to treat a digestive disorder. Now she appears to be suffering from what she calls “permanent central nervous system damage.”
Warner Chilcott, the makers of Sarafem (fluoxetine hydrochloride), a treatment for Premenstrual Dysphoric Disorder (PMDD), have issued a warning about the risk of neuroleptic malignant syndrome, also known as Tardive Dyskinesia, a condition in which a person develops involuntary movements of his muscles similar to Parkinson’s Disease.
The FDA’s “black box warning” on the acid reflux drug Reglan is long overdue, according to Jennifer Rackley. Both her daughters as infants were on the medication. Her first had severe GERD and was categorized by doctors as “failure to thrive.” Her pediatrician prescribed Reglan, a brand name of metaclopramide. “At the time we were not aware of the side effects nor did we have any major qualms about using the medication,” Jennifer said. “Boy was that about to change!”
Nursing mothers who have difficulty establishing or maintaining breast milk production may be prescribed medication to increase the amount of breast milk they produce. One popular choice has been metoclopramide, most commonly known as Reglan.
Last March, the U.S. Supreme Court upheld a $6.7 million ruling stating that federal law cannot protect pharmaceutical companies from liability lawsuits that are filed in state court, meaning drug companies are responsible for damages created by products even when the FDA has approved drug labels that include warnings of side effects. That ruling is based on a lawsuit involving Wyeth Pharmaceutical drug Phenergan. As a result of the ruling, numerous lawsuits against pharmaceutical companies that had been lying dormant are finally beginning to move toward trial, according to Bloomberg.
This is a YouTube user’s wife. She suffers from tardive dyskinesia as a result of being over-prescribed the atypical antipsychotic Geodon. Tardive dyskinesia is a condition in which a person develops involuntary movements of their muscles, which can include lip smacking, tongue thrusting, eye blinking and buldging, head jerking, facial grimacing, pucker and pursing of the lips, and involuntary movements of the fingers.
